ApprovalTrail

Approval · Notice of Compliance 19647 · 2017

MATULANE: Notice of Compliance 19647

Issued August 10, 2017

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
19647
Date
August 10, 2017
Company
Leadiant Biosciences, Inc.Scarborough, Ontario, Canada
Product type
Prescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
Admin
Reason
Manufacturer nae change

Products in this notice

BrandDINStatus today
MATULANE00012750Marketed

Medicinal ingredients